Qiagen NV (QGEN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Qiagen NV’s revenue went from $1.3B in fiscal 2016 to $2.1B in fiscal 2025, growth of about 5.1% a year.
Net income in fiscal 2025 was $425M, a net margin of 20.3%; the best year in this period was 2021 with $513M.
Over the twelve months to September 30, 2026, revenue was $2.1B and net income $385M.
Free cash flow was $453M in fiscal 2025 and positive in 10 of the 10 years shown.
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.0B | $2.0B | $2.1B | $2.3B | $1.9B | $1.5B | $1.5B | $1.4B | $1.3B |
| Gross profit | — | $1.3B | $967M | $1.2B | $1.4B | $1.5B | $1.2B | $1.0B | $1.0B | $923M | $845M |
| Operating income | — | $466M | $98M | $410M | $531M | $630M | $386M | -$26M | $267M | $153M | $99M |
| Net income | $385M | $425M | $84M | $341M | $423M | $513M | $359M | -$41M | $190M | $40M | $80M |
| EPS (diluted) | $1.85 | $2.06 | $0.41 | $1.66 | $2.05 | $2.49 | $1.74 | $-0.20 | $0.92 | $0.20 | $0.39 |
| R&D | — | $188M | $193M | $199M | $190M | $190M | $149M | $157M | $162M | $154M | $150M |
| Revenue growth | — | +5.7% | +0.7% | −8.2% | −4.9% | +20.4% | +22.5% | +1.6% | +5.9% | +5.9% | +4.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $635M | $654M | $674M | $459M | $715M | $639M | $458M | $331M | $359M | $287M | $342M |
| Capital spending | -$203M | -$201M | -$167M | -$150M | -$129M | -$190M | -$133M | -$118M | -$110M | -$90M | -$75M |
| Free cash flow | $432M | $453M | $506M | $310M | $586M | $449M | $325M | $213M | $250M | $197M | $267M |
| Dividends paid | $72M | $54M | $0 | $0 | — | — | — | — | — | — | — |
| Buybacks | — | $280M | $292M | $0 | $0 | $100M | $64M | $74M | $105M | $61M | $0 |
| Stock-based pay | — | $50M | $44M | $47M | $50M | $38M | $41M | $66M | $40M | $34M | $28M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.1B | $1.2B | $1.1B | $1.4B | $1.1B | $715M | $753M | $1.4B | $1.0B | $532M |
| Debt | — | $1.8B | $1.5B | $1.6B | $2.0B | $2.0B | $2.0B | $1.8B | $2.2B | $1.8B | $1.1B |
| Equity | — | $3.8B | $3.6B | $3.8B | $3.5B | $3.1B | $2.8B | $2.5B | $2.6B | $2.5B | $2.6B |
| Total assets | — | $6.3B | $5.7B | $6.1B | $6.3B | $6.1B | $5.9B | $5.2B | $5.7B | $5.0B | $4.3B |
| Shares (diluted) | 208M | 206M | 206M | 206M | 206M | 206M | 206M | 206M | 206M | 206M | 206M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 62.2% | 48.9% | 62.8% | 64.6% | 64.4% | 65.9% | 65.9% | 66.6% | 65.1% | 63.1% |
| Operating margin | — | 22.3% | 4.9% | 20.9% | 24.8% | 28.0% | 20.7% | -1.7% | 17.8% | 10.8% | 7.4% |
| Net margin | 18.2% | 20.3% | 4.2% | 17.4% | 19.8% | 22.8% | 19.2% | -2.7% | 12.7% | 2.9% | 6.0% |
| FCF margin | 20.4% | 21.7% | 25.6% | 15.8% | 27.4% | 20.0% | 17.4% | 14.0% | 16.6% | 13.9% | 20.0% |
| ROIC | — | 7.2% | 1.3% | 6.0% | 8.1% | 10.1% | 6.5% | -0.3% | 4.7% | 2.8% | 2.1% |
| ROE | — | 11.2% | 2.3% | 9.0% | 12.2% | 16.6% | 12.8% | -1.6% | 7.2% | 1.6% | 3.1% |
Frequently asked questions
What is Qiagen NV’s annual revenue?
$2.1B in fiscal 2025 and $2.1B over the twelve months to September 30, 2026.
How much profit does Qiagen NV make?
Net income was $425M in fiscal 2025 (net margin 20.3%).
Is Qiagen NV’s revenue growing?
Yes: revenue rose 5.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.